5 Best Healthcare Stocks to Buy According to Billionaire Larry Robbins

3. McKesson Corporation (NYSE:MCK)

Glenview Capital’s Stake Value: $286,550,000

Percentage of Glenview Capital’s 13F Portfolio: 5.8%

Number of Hedge Fund Holders: 59

McKesson Corporation (NYSE:MCK) provides healthcare services in the United States and internationally. The company has four business segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions. As of Q1 2022, Glenview Capital’s stakes in McKesson Corporation (NYSE:MCK) are valued at $286.55 million. The investment covers 5.8% of Larry Robbins’ 13F portfolio.

On May 31, McKesson Corporation (NYSE:MCK) reported that Britt Vitalone, the company’s CFO sold 27,300 shares of common stock on May 27 for a transaction of $9.1 million.

On June 7, Deutsche Bank analyst George Hill reiterated his price target of $378 on McKesson Corporation (NYSE:MCK) and upgraded the stock to Buy from Hold.

Insider Monkey found 59 hedge funds bullish on McKesson Corporation (NYSE:MCK) at the close of Q1 2022. These funds held collective stakes worth $3.79 billion in the company, up from $2.55 billion in the previous quarter with 57 positions. The hedge fund sentiment for the stock is positive.

Here is what Baron Funds had to say about McKesson Corporation (NYSE:MCK) in its first-quarter 2022 investor letter:

“Investments in health care distributors, health care services, and health care facilities along with cash exposure in a down market contributed to relative results. Within health care distributors, higher exposure to this strong performing sub-industry and outperformance of pharmaceutical distributor and technology solutions provider McKesson Corporation (NYSE:MCK) added value. McKesson was the top contributor as investors rotated into value stocks that were trading at low multiples of earnings. We continue to believe that McKesson’s stock is inexpensive in light of the company’s strong competitive position in growing end markets and earnings growth potential.”